Authors:
ABIGERGES D
CHABOT GG
ARMAND JP
HERAIT P
GOUYETTE A
GANDIA D
Citation: D. Abigerges et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS, Journal of clinical oncology, 13(1), 1995, pp. 210-221
Authors:
ABIGERGES D
ARMAND JP
CHABOT GG
DACOSTA L
FADEL E
COTE C
HERAIT P
GANDIA D
Citation: D. Abigerges et al., IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA, Journal of the National Cancer Institute, 86(6), 1994, pp. 446-449
Authors:
SPIELMANN M
GANDIA D
FIZAZI K
GUILLOT T
CVITKOVIC E
KAYITALIRE L
GIRINSKY T
ELIAS D
ROUGIER P
KAC J
Citation: M. Spielmann et al., PHASE-II STUDY OF 4'-EPIRUBICIN IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 30A(12), 1994, pp. 1908-1909
Citation: E. Cvitkovic et al., CASE-REPORT OF ACQUIRED PIRITREXIM RESISTANCE AND COLLATERAL METHOTREXATE SENSITIVITY IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Journal of the National Cancer Institute, 85(15), 1993, pp. 1248-1248
Authors:
ARMAND JP
CVITKOVIC E
RECONDO G
WIBAULT P
SCHWAAB G
DOMENGE C
TELLEZBERNAL E
GANDIA D
LUBOINSKI B
ESCHWEGE F
DEFORNI M
Citation: Jp. Armand et al., SALVAGE CHEMOTHERAPY IN RECURRENT HEAD AND NECK-CANCER - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE, American journal of otolaryngology, 14(5), 1993, pp. 301-306